08 October 2019
Visiongain has published a new pharma report Global Surgical Sutures Market Report: Absorbable Sutures, Non-Absorbable Sutures, Automated Suturing Devices, General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Gynaecological Surgery, Ophthalmic Surgery, Facial, Cosmetic & Plastic Surgery.
The global surgical sutures market is expected to reach $6.4bn in 2024 and is estimated to grow at a CAGR of 5.1% from 2019-2024. The Absorbable Sutures submarket held 52% of the global surgical sutures market in 2019.The global anaesthesia drugs market is projected to grow at lucrative rate during the forecast period owing to a rising number of surgical procedures globally, developing healthcare infrastructure in emerging economies, and growing number of geriatric population.
This report profiled the selected companies: AD Surgical, B. Braun Melsungen AG, Bioline Fios Cirúrgicos Ltda, CP Medical, DemeTech Corporation, Ethicon, Inc., Internacional Farmacéutica, Medtronic Plc, Péters Surgical, Riverpoint Medical and other companies.
The lead analyst commented that "The global market for surgical sutures is witnessing steady growth primarily due to the increasing number of surgical procedures conducted, globally. The favorable reimbursement scenario for a number of surgical procedures and the launch of advanced sutures are further contributing to the market growth."
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
29 July 2021
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
21 July 2021
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
20 July 2021
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.